| 15.71 5.36 (51.79%) | 11-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 18.62 |
1-year : | 21.75 |
| Resists | First : | 15.94 |
Second : | 18.62 |
| Pivot price | 10.91 |
|||
| Supports | First : | 6.4 |
Second : | 0.5 |
| MAs | MA(5) : | 11.56 |
MA(20) : | 10.99 |
| MA(100) : | 3.49 |
MA(250) : | 2.06 |
|
| MACD | MACD : | 1.7 |
Signal : | 1.6 |
| %K %D | K(14,3) : | 53.3 |
D(3) : | 36.6 |
| RSI | RSI(14): 65.2 |
|||
| 52-week | High : | 15.94 | Low : | 0.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SKIN ] has closed above the upper band by 39.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 22.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.96 - 16.04 | 16.04 - 16.11 |
| Low: | 11.38 - 11.45 | 11.45 - 11.51 |
| Close: | 15.58 - 15.71 | 15.71 - 15.83 |
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Fri, 06 Nov 2026
Beauty Health Q3 Earnings Call Highlights - Yahoo Finance
Fri, 06 Nov 2026
Is a 40.39% Pop in SkinHealth Systems (NASDAQ:SKIN) Linked to a Narrower Quarterly Loss? - kalkine.ca
Fri, 06 Nov 2026
SkinHealth Systems Inc (SKIN) Q3 2026 Earnings Call Highlights: - GuruFocus
Thu, 05 Nov 2026
SkinHealth Systems Inc. (SKIN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Thu, 05 Nov 2026
SkinHealth Systems Inc. (SKIN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Thu, 05 Nov 2026
SkinHealth Systems (SKIN): Net loss narrows to $888K in quarter; 2026 Notes gains noted - Quantisnow
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 7 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 12.8 (%) |
| Held by Institutions | 77 (%) |
| Shares Short | 362 (K) |
| Shares Short P.Month | 360 (K) |
| EPS | -4.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.53 |
| Profit Margin | -9.9 % |
| Operating Margin | 4.9 % |
| Return on Assets (ttm) | -0.6 % |
| Return on Equity (ttm) | -43.9 % |
| Qtrly Rev. Growth | -7.9 % |
| Gross Profit (p.s.) | 29.56 |
| Sales Per Share | 44.55 |
| EBITDA (p.s.) | 3.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 22 (M) |
| Levered Free Cash Flow | 27 (M) |
| PE Ratio | -3.42 |
| PEG Ratio | 0.9 |
| Price to Book value | 1.83 |
| Price to Sales | 0.35 |
| Price to Cash Flow | 4.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|